ClinicalTrials.gg
TerminatedNCT03493633EzyGainUpdated Mar 21, 2023

Use EzyGain at Home (Device for Walking at Home)

An observational study in Physical Disability and Physical Activity, sponsored by Assistance Publique - Hôpitaux de Paris. Terminated at 1 site in France. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2023-03-21.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

Why this study was terminated
early termination - fault of inclusion
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
15
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 18 studies in Motor Activity by Assistance Publique - Hôpitaux de Paris — none open to participants now, 1 under way, none of them phase 3. Motor Activity · Assistance Publique - Hôpitaux de Paris.

Started
2018
the only one that year
Observational
5 of 18
none open now
Registered
10th of 18
by date

Among the 18 studies in Motor Activity by Assistance Publique - Hôpitaux de Paris, this one is the only one that started in 2018, is one of 5 observational ones, and was the 10th registered.

Motor Activity

9,798 studies on the registry are indexed under Motor Activity; 1,910 are open to participants now.

Browse Motor Activity studies →

Open to participants now

None of the 18 studies in Motor Activity by Assistance Publique - Hôpitaux de Paris is open now.

Where they have run

Who these studies take

Of the 1,201 Motor Activity studies recruiting now, 517 (43%) set no upper age limit and 535 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 60 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 18 studies in Motor Activity by Assistance Publique - Hôpitaux de Paris as a file.
02

Study summary

Our research hypothesis is that the practice of walking on a secure treadmill is possible at home and allows the patient to increase the training work of walking in everyday life compared to a conventional care.

Read the detailed description

Our research hypothesis is that the practice of walking on a secure treadmill is possible at home and allows the patient to increase the work of training of walking in everyday life compared to a conventional care. In addition, we believe that this practice should be supervised by a caregiver trained by the physiotherapist / APA investigator, in order to increase the use of the device.

The people concerned by this protocol are those who have a partial disability of walking whatever the pathology and the underlying deficiencies.

Main objective: To evaluate the feasibility of using EzyGain at home.

Main Evaluation Criteria: Number of sessions performed on the device during the duration of the study, compared to the number of scheduled sessions.

Secondary objectives

Secondary objective 1: make a partial transfer of the supervision of the physiotherapist / APA investigator's sessions to the caregiver.

Secondary Objective 2: To evaluate whether the exercise period on the device increases the amount of spontaneous physical activity of the patient after the end of the period compared to the average spontaneous physical activity prior to the exercise period.

Population concerned:

Population over 60 years of age with partial walking disability regardless of etiology and pathology leading to walking disability.

Population coming into consultation in the services of Dr. Teixeira and Pr. Yelnik of GH Saint Louis Lariboisière Fernand Widal.

Partial incapacity of walking. Availability at home during their participation period (weeks of walking exercise + weeks of evaluation of physical activity).

Ethnicity indifferent Indifferent sex Patient with a close volunteer caregiver to participate in the study and receive training from the investigator / APA investigator and then manage sessions autonomously.

Anyone who would like to train more regularly on the walk and at home because unable to go out.

Who uses or does not use technical assistance to walk or move Patient who falls or is at risk of falling and, as a result, limits his progress.

Possibility of installation of the device in the patient's home. Patient affiliated to a social security scheme

Practical sequence:

Selection and medical inclusion of the patient by one of the investigating physicians and delivery of consent. During this visit, the doctor judges the eligibility criteria, explains the research to the patient, gives him the informed consent that is signed on the spot.

Among the eligibility criteria, there must be a caregiver close to the patient, who is willing to participate in the research. If he is present during this visit, he signs his consent to participate in the research. If he is absent during this visit, the patient gives his coordinates, the doctor calls him to explain the research, and sends his consent by mail, which the caregiver returns signed by mail to the doctor. It only remains to verify that the apartment can accommodate the device EzyGain.

Evaluation of the accessibility of the home by the EzyGain team. If the apartment can accommodate the device, then the patient is included in the search. If the apartment can not accommodate the device, then the patient is not included.

The first visit takes place on site with the investigator / APA investigator and an investigator. Laying the Actigraph ©.

Evaluation of the spontaneous physical activity of the patient by actimetry for seven days + QAPPA (questionnaire of physical activity for old person).

Beginning of the training phase on the device. The dosage of the activity (frequency of sessions and practical content) and the possibility of supervising additional sessions by a family caregiver is determined by the investigating physiotherapist / APA investigator.

Each patient performs a minimum of 3 sessions per week with the investigator / APA investigator, for 4 weeks, each walk for a few minutes (\<60 min).

Evaluation of the spontaneous physical activity of the patient by actimetry for seven days QAPPA (questionnaire of physical activity for elderly person) a week and a month after the training phase of four weeks

03

Conditions studied

  • Physical Disability
  • Physical Activity

Browse trials for

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Population over 60 years of age with partial walking disability regardless of etiology and pathology leading to walking disability.

Population coming into consultation in the services of Dr. Teixeira and Pr. Yelnik of GH Saint Louis Lariboisière Fernand Widal.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Person over the age of 60
  • Availability at home during their participation period (walking exercise weeks + physical activity assessment weeks).
  • Patient with a volunteer close caregiver to participate in the study and receive training from the investigator/APA investigator and then manage autonomy sessions.
  • Person who would like to train more regularly in the walk and at home because unable to get out. Person who uses or does not use technical assistance to walk or move
  • Person in a State to sign alone
  • Possibility of installation of the device in the patient's home (the dimensions of the lift/doors/parts allow the device to be entered in the apartment, as well as not to hinder the daily life of the patient too heavily).
  • Patient affiliated with a Social security plan
  • Person who has a partial limitation of walking activity (partial inability to walk) and in whom, re-education of walking is relevant to improve performance (whether or not the patient does this re-education at the time of the visit of selection). The criteria for limiting walking activity are:
  • Speed limitation
  • Endurance limitation
  • Limitation of the operating perimeter
  • Limitation of the dynamic balancing during walking failure to position the foot or feet during walking
  • Falls
  • Availability at home during their time of participation.
  • Indifferent ethnic origin
  • Indifferent sex

Exclusion criteria

Exclusion Criteria:

  • Uncontrolled heart failure
  • Uncontrolled respiratory insufficiency
  • Uncontrolled coronary insufficiency
  • Impossibility of installing the device at home
  • Severe cognitive impairment with risk of using the device alone, outside of the instructions
  • Absence of a caregiver to follow a continuous training of the physiotherapist / - APA investigator to supervise independently one or two sessions per week
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
15 participants (actual)
Target follow-up
9 Weeks
Patient registry
Yes

Groups and cohorts

  • EzyGain at Home

    Setting up a walking device at home for people aged 60 years with partial walking disability regardless of etiology and pathology leading to walking disability.

    Device: EzyGain

Interventions

  • DeviceEzyGain

    Each patient performs a minimum of 3 sessions per week with the investigator / APA investigator, for 4 weeks, each walk for a few minutes (\<60 min). Evaluation of the spontaneous physical activity of the patient by actimetry for seven days QAPPA (questionnaire of physical activity for elderly person) a week and a month after the training phase of four weeks

06

What researchers measure

Primary outcomes

  1. Number of sessions performed on the device during the duration of the study

    Count of the number of sessions performed. A session is considered to be performed when the patient is walking for at least one minute on the EzyGain treadmill with the APA investigator / caregiver.

    Time frame: Up to 4 weeks

Secondary outcomes

  1. Number of sessions performed autonomously by the caregiver

    Measure of the number of self-help sessions performed by the caregiver and their proportion to the total number of sessions completed.

    Time frame: Up to 4 weeks

  2. Physical activity evaluate by actimetry before the training period

    Evaluate spontaneous physical activity by actimetry over a continuous period of 7 days before the beginning of the exercise period. At day #1 of the 7-day period : put the Actigraph© on the patient At day #7 of the 7-day period : take the Actigraph© off the patient

    Time frame: At days 7 before the training period

  3. Physical activity evaluate by QAPPA before the training period

    Evaluate spontaneous physical activity by QAPPA, 7 days before the beginning of the exercise period. At day #7 of the 7-day period do the QAPPA

    Time frame: At days 7 before the training period

  4. Physical activity evaluate by actimetry just after the training period

    Evaluate spontaneous physical activity by actimetry over a continuous period of 7 days starting the day after the end of the exercise period. At day #1 of the 7-day period : put the Actigraph© on the patient At day #7 of the 7-day period : take the Actigraph© off the patient

    Time frame: At days 7 after the end of the training period

  5. Physical activity evaluate by QAPPA just after the training period

    Evaluate spontaneous physical activity by QAPPA over period of 7 days starting the day after the end of the exercise period. At day #7 of the 7-day period do the QAPPA

    Time frame: At days 7 after the end of the training period

  6. Physical activity evaluate by actimetry 3 weeks after the training period

    Evaluate spontaneous physical activity by actimetry over a continuous period of 7 days starting 3 weeks after the end of the exercise period. At day #1 of the 7-day period : put the Actigraph© on the patient At day #7 of the 7-day period : take the Actigraph© off the patient

    Time frame: At 3 weeks after the training period

  7. Physical activity evaluate by QAPPA 3 weeks after the training period

    Evaluate spontaneous physical activity by QAPPA over a continuous period of 7 days starting 3 weeks after the end of the exercise period. At day #7 of the 7-day period do QAPPA

    Time frame: At 3 weeks after the training period

07

Study locations

1 site
  • Service de Médecine Physique et de Réadaptation - Hôpital F.Widal
    Paris, 75010, France
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2018 to primary completion in Mar 2021, 31 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 1, 2018
First posted
Apr 10, 2018
StartActual
Jul 31, 2018
Primary completionActual
Mar 15, 2021
CompletionActual
Mar 15, 2021
Last update
Mar 21, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03493633
Responsible party
Sponsor
First posted
Apr 10, 2018
Start date
Jul 31, 2018
Primary completion
Mar 15, 2021
Completion
Mar 15, 2021
Last update
Mar 21, 2023

Study contacts

Alain YELNIK
principal investigator · Assistance Publique - Hôpitaux de Paris

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion